ICLR Competitors & Alternatives
Compare ICON PLC with similar stocks in the same industry
Diagnostics & Research
ICLR
Main Stock$199.70
Tradestie Score
31
Market Cap
$14.96B
P/E Ratio
81.9
Revenue Growth
0.0%
Analyst Upside
+15.8%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NTRA
Natera, Inc. Common Stock
|
$319.82
|
$22.18B | - | 65 | Compare |
|
DGX
Quest Diagnostics Inc.
|
$258.69
|
$20.36B | 25.7 | 38 | Compare |
|
WST
West Pharmaceutical Services, Inc.
|
$412.86
|
$19.52B | 46.3 | 50 | Compare |
|
WAT
Waters Corp
|
$470.90
|
$19.04B | 199.0 | 48 | Compare |
|
ILMN
Illumina Inc
|
$212.93
|
$15.72B | 37.0 | 62 | Compare |
|
MEDP
Medpace Holdings, Inc. Common Stock
|
$664.77
|
$15.28B | 36.9 | 54 | Compare |
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 52 | Compare |
|
RVTY
Revvity, Inc.
|
$158.25
|
$10.65B | 71.7 | 51 | Compare |
|
QGEN
QIAGEN N.V.
|
$50.30
|
$10.04B | 27.3 | 44 | Compare |
|
CRL
Charles River Laboratories International, Inc.
|
$342.69
|
$8.39B | 375.9 | 44 | Compare |
More ICLR Analysis
Data updated: Nov 12, 2026 | Industry: Diagnostics & Research (SIC 8731)
36 stocks in this industry